SCHEMBL1397437

SCHEMBL1397437

CC(=O)CC1CCCC1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
PTGS1 P23219 8/20 0.43
PTGS2 P35354 8/20 0.43
OPRK1 P41145 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
GAA P10253 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
TLR4 O00206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1188324 0.94 NPC1 (0.46) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL1981599 0.92 CA1 (0.46) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL1978465 0.92 CA1 (0.46) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL28365490 0.92 CA1 (0.46) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL9079832 0.82 NPC1 (0.41) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL1918364 0.81 L3MBTL1 (0.46) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL2431325 0.80 NPC1 (0.58) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL13545147 0.80 PTGS1 (0.44) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL2013833 0.80 NPC1 (0.40) NPC1RAB9ASMN1; SMN2LMNAPTGS1
SCHEMBL2013836 0.80 NPC1 (0.40) NPC1RAB9ASMN1; SMN2LMNAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283550-B1 CATALYST CONTAINING AMIDINE GROUPS SIKA TECH AG (CH) 2020-12-16 EP disclosed
EP-3294803-B1 GUANIDINE GROUP CONTAINING CATALYST SIKA TECH AG (CH) 2020-12-09 EP disclosed
CN-107428941-B Amidino group-containing catalyst SIKA技术股份公司 2020-11-24 CN disclosed
CN-107735438-B Guanidino-containing catalysts SIKA技术股份公司 2020-06-09 CN disclosed
US-10414875-B2 Catalyst containing guanidine groups SIKA TECHNOLOGY AG (CH) 2019-09-17 US disclosed
US-10392480-B2 Catalyst containing amidine groups SIKA TECHNOLOGY AG (CH) 2019-08-27 US disclosed
EP-2288640-B1 WATER SOLUBLE AMINE AND ITS APPLICATION SIKA TECH AG (CH) 2018-09-19 EP disclosed
US-20180171082-A1 CATALYST CONTAINING AMIDINE GROUPS SIKA TECHNOLOGY AG (CH) 2018-06-21 US disclosed
US-20180148545-A1 CATALYST CONTAINING GUANIDINE GROUPS SIKA TECHNOLOGY AG (CH) 2018-05-31 US disclosed
EP-3294803-A1 CATALYST CONTAINING GUANIDINE GROUPS Sika Technology AG (CH) 2018-03-21 EP disclosed
EP-2288639-A1 POLYAMINE HAVING A REDUCED BLUSHING EFFECT, AND USE THEREOF AS A CURING AGENT FOR EPOXY RESINS Sika Technology AG (CH) 2011-03-02 EP disclosed
EP-2288640-A1 WATER-SOLUBLE AMINE AND USES THEREOF Sika Technology AG (CH) 2011-03-02 EP disclosed
WO-2010039982-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2010-04-08 WO disclosed
WO-2010039982-A1 CRTH2 MODULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2010-04-08 WO disclosed
WO-2009150212-A1 WATER-SOLUBLE AMINE AND USES THEREOF SIKA TECHNOLOGY AG (CH) 2009-12-17 WO disclosed
WO-2009150219-A1 POLYAMINE HAVING A REDUCED BLUSHING EFFECT, AND USE THEREOF AS A CURING AGENT FOR EPOXY RESINS SIKA TECHNOLOGY AG (CH) 2009-12-17 WO disclosed
EP-2133378-A1 Polyamine with reduced blushing and its application as hardener for epoxy resin Sika Technology AG (CH) 2009-12-16 EP disclosed
EP-2133381-A1 Water soluble amine and its application Sika Technology AG (CH) 2009-12-16 EP disclosed
US-7332492-B2 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor ASTRAZENECA AB (SE) 2008-02-19 US disclosed
US-7332492-B2 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor ASTRAZENECA AB (SE) 2008-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414875-B2 Catalyst containing guanidine groups GMPS, GMNN, RNMT NPC1 3733/4885RAB9A 1813/4885SMN1; SMN2 172/4885
US-20180148545-A1 CATALYST CONTAINING GUANIDINE GROUPS GMPS, RNMT, GMNN NPC1 3631/4885RAB9A 1485/4885SMN1; SMN2 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.